Kentucky Biomarker Bill: The Right Test for the Right Treatment

Author: Dr. JP Canner, Ph.D., NRCC, MT(AAB) The right test for the right treatment.    The Commonwealth of Kentucky enacted HB180 this year which mandates insurance coverage of biomarker testing.  Kentucky joins 13 other states with legislation addressing this complex issue.   Biomarkers can either be direct targets or closely associated indicators of a disease. …

Read More

PGx: Truth, Hope, and Hype

Author: Dr. JP Canner, Ph.D., NRCC, MT(AAB) Pharmacogenetics (PGx) is the practice of applying the knowledge of an individual’s genes to guide the best therapeutic options.  Given the generality of this definition, there are numerous ways to implement PGx in practice.  In this article, we’ll cover the basics of PGx, detailing what it is and…

Read More

Gravity Diagnostics Expands Testing Services to Include Xylazine Detection: A Crucial Advancement in Ensuring Public Safety

  [[Covington, KY] – [9/20/23] – Gravity Diagnostics, a leading clinical toxicology laboratory, is announcing a significant expansion of their testing services. They are now offering comprehensive testing for Xylazine, a powerful sedative and muscle relaxant. This groundbreaking addition to their testing portfolio demonstrates their unwavering commitment to advancing public health and safety. Xylazine, originally…

Read More

Gravity Diagnostics Receives $20 Million Line of Credit from PNC Bank to Support COVID-19 Testing

COVINGTON, Ky., Jan. 12, 2021 /PRNewswire/ — Gravity Diagnostics has announced that PNC Bank has authorized a $20 million line of credit to the diagnostics laboratory to support investments in inventory, equipment, and operations to increase its capacity and capabilities. Gravity Diagnostics is a full-service CLIA laboratory licensed in all 50 states providing laboratory testing in the areas of COVID-19,…

Read More